Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
38.84
+0.66 (1.73%)
At close: Aug 22, 2025, 4:00 PM
38.07
-0.77 (-1.98%)
After-hours: Aug 22, 2025, 7:32 PM EDT

Xenon Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
2,9952,9893,5032,4661,643554
Upgrade
Market Cap Growth
-18.38%-14.68%42.03%50.06%196.62%57.13%
Upgrade
Enterprise Value
2,3792,1952,8751,7211,397364
Upgrade
Last Close Price
38.8439.2046.0639.4331.2415.38
Upgrade
PS Ratio
399.31--261.4189.1417.22
Upgrade
PB Ratio
4.713.963.783.422.993.23
Upgrade
P/TBV Ratio
4.723.963.783.422.993.23
Upgrade
PEG Ratio
-2.512.512.512.512.51
Upgrade
EV/Sales Ratio
317.15--182.4475.7711.31
Upgrade
Debt / Equity Ratio
0.010.010.010.010.020.02
Upgrade
Asset Turnover
0.01--0.010.050.19
Upgrade
Quick Ratio
14.7917.6623.4326.1238.7212.10
Upgrade
Current Ratio
15.1417.8523.6526.4439.0312.30
Upgrade
Return on Equity (ROE)
-37.65%-27.85%-22.12%-19.72%-21.87%-21.90%
Upgrade
Return on Assets (ROA)
-25.52%-19.80%-15.57%-12.17%-12.97%-11.61%
Upgrade
Return on Capital (ROIC)
-26.57%-20.50%-16.01%-12.51%-13.47%-13.82%
Upgrade
Earnings Yield
-9.29%-7.84%-5.21%-5.08%-4.80%-5.21%
Upgrade
FCF Yield
-7.73%-6.17%-4.47%-4.21%-4.35%-9.16%
Upgrade
Buyback Yield / Dilution
-7.80%-16.45%-10.48%-38.77%-21.09%-23.57%
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q